What are so ‘innovative’ about ‘NOAC’ applauded by physicians?
Foreign and domestic guidelines, recently, have aggressively recommended NOAC(New-Oral Anti-Coagulant) as an anticoagulant to prevent stoke and systemic embolism of atrial fibrillation patients.
Thus, NOAC has been available to acquire the health insurance benefit as the primary treatment since ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
